Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New gout drug shows promise in major trial

NCT ID NCT06846515

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 01, 2026 · Updated 2 times

Summary

This study tests a new medicine called AR882 to see if it can lower uric acid levels in people with gout. About 750 adults with gout will receive either AR882 or a placebo for 12 months. The main goal is to see if AR882 helps more patients reach a safe uric acid level and reduce gout flares and tophi (lumps under the skin).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 750 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * History of gout * Occurrence of ≥ 2 self-reported gout flares in the last 12 months * Body weight no less than 50 kg * Patients who are NOT on approved urate-lowering therapy (ULT) must have sUA ≥ 7 mg/dL * Patients who are on medically appropriate ULT must have sUA \> 6 mg/dL * Serum creatinine must be \< 3.0 mg/dL and estimated CLcr ≥ 30 mL/min Exclusion Criteria: * Malignancy within 5 years, except for successfully treated basal or squamous cell carcinoma of the skin * Pregnant or breastfeeding * History of symptomatic kidney stones within the past 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arthritis, gouty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arthritis, Gouty gout Hyperuricemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Arthrosi Investigative Site (600)

    Tampa, Florida, 33609, United States

  • Arthrosi Investigative Site (601)

    Houston, Texas, 77074, United States

  • Arthrosi Investigative Site (603)

    Santa Monica, California, 90404, United States

  • Arthrosi Investigative Site (604)

    Fort Mill, South Carolina, 29707, United States

  • Arthrosi Investigative Site (605)

    Lomita, California, 90717, United States

  • Arthrosi Investigative Site (608)

    North Charleston, South Carolina, 29405, United States

  • Arthrosi Investigative Site (609)

    Salt Lake City, Utah, 84121, United States

  • Arthrosi Investigative Site (610)

    Lincoln, Nebraska, 68516, United States

  • Arthrosi Investigative Site (611)

    Miami, Florida, 33173, United States

  • Arthrosi Investigative Site (612)

    Fort Collins, Colorado, 80528, United States

  • Arthrosi Investigative Site (613)

    Jupiter, Florida, 33458, United States

  • Arthrosi Investigative Site (614)

    Garden Grove, California, 92844, United States

  • Arthrosi Investigative Site (615)

    Sanford, Florida, 32771, United States

  • Arthrosi Investigative Site (616)

    Huntsville, Alabama, 35801, United States

  • Arthrosi Investigative Site (617)

    Little Rock, Arkansas, 72205, United States

  • Arthrosi Investigative Site (618)

    La Mesa, California, 91942, United States

  • Arthrosi Investigative Site (619)

    Chattanooga, Tennessee, 37404, United States

  • Arthrosi Investigative Site (620)

    Birmingham, Alabama, 35215, United States

  • Arthrosi Investigative Site (623)

    Philadelphia, Pennsylvania, 19107, United States

  • Arthrosi Investigative Site (624)

    Hendersonville, Tennessee, 37075, United States

  • Arthrosi Investigative Site (625)

    Charlotte, North Carolina, 28207, United States

  • Arthrosi Investigative Site (626)

    Town and Country, Missouri, 63017, United States

  • Arthrosi Investigative Site (627)

    Mandeville, Louisiana, 70471, United States

  • Arthrosi Investigative Site (628)

    Farmington Hills, Michigan, 48334, United States

  • Arthrosi Investigative Site (631)

    Norman, Oklahoma, 73072, United States

  • Arthrosi Investigative Site (632)

    Lincoln, California, 95648, United States

  • Arthrosi Investigative Site (633)

    Gulfport, Mississippi, 39503, United States

  • Arthrosi Investigative Site (634)

    Meridian, Idaho, 83642, United States

  • Arthrosi Investigative Site (635)

    Jackson, Mississippi, 39202, United States

  • Arthrosi Investigative Site (636)

    Fall River, Massachusetts, 02721, United States

  • Arthrosi Investigative Site (637)

    Springfield, Missouri, 65807, United States

  • Arthrosi Investigative Site (638)

    Charleston, South Carolina, 29407, United States

  • Arthrosi Investigative Site (639)

    DeSoto, Texas, 75115, United States

  • Arthrosi Investigative Site (640)

    Phoenix, Arizona, 85018, United States

  • Arthrosi Investigative Site (641)

    Prairieville, Louisiana, 70769, United States

  • Arthrosi Investigative Site (642)

    Tulsa, Oklahoma, 74133, United States

  • Arthrosi Investigative Site (643)

    Clinton, Utah, 84015, United States

  • Arthrosi Investigative Site (644)

    Miami, Florida, 33176, United States

  • Arthrosi Investigative Site (645)

    Southfield, Michigan, 48076, United States

  • Arthrosi Investigative Site (646)

    Tomball, Texas, 77375, United States

  • Arthrosi Investigative Site (647)

    Horsham, Pennsylvania, 19044, United States

  • Arthrosi Investigative Site (648)

    Melrose Park, Illinois, 60160, United States

  • Arthrosi Investigative Site (649)

    Shelby, North Carolina, 28150, United States

  • Arthrosi Investigative Site (650)

    New Orleans, Louisiana, 70115, United States

  • Arthrosi Investigative Site (651)

    Omaha, Nebraska, 68144, United States

  • Arthrosi Investigative Site (652)

    Marietta, Georgia, 30060, United States

  • Arthrosi Investigative Site (653)

    Rockville, Maryland, 20852, United States

  • Arthrosi Investigative Site (654)

    Salt Lake City, Utah, 84124, United States

  • Arthrosi Investigative Site (655)

    La Palma, California, 90623, United States

  • Arthrosi Investigative Site (656)

    Thousand Oaks, California, 91360, United States

  • Arthrosi Investigative Site (657)

    Chicago, Illinois, 60602, United States

  • Arthrosi Investigative Site (658)

    Honolulu, Hawaii, 96814, United States

  • Arthrosi Investigative Site (659)

    Tomball, Texas, 77375, United States

  • Arthrosi Investigative Site (660)

    Aurora, Colorado, 80012, United States

  • Arthrosi Investigative Site (661)

    Brooklyn, New York, 11215, United States

  • Arthrosi Investigative Site (662)

    Oxon Hill, Maryland, 20745, United States

  • Arthrosi Investigative Site (663)

    Hartsdale, New York, 10530, United States

  • Arthrosi Investigative Site (664)

    Missoula, Montana, 59808, United States

  • Arthrosi Investigative Site (665)

    Cooper City, Florida, 33024, United States

  • Arthrosi Investigative Site (666)

    Fargo, North Dakota, 58104, United States

  • Arthrosi Investigative Site (668)

    Kenosha, Wisconsin, 53144, United States

  • Arthrosi Investigative Site (669)

    Colorado Springs, Colorado, 80909, United States

  • Arthrosi Investigative Site (670)

    Amarillo, Texas, 79106, United States

  • Arthrosi Investigative Site (671)

    Mason, Ohio, 45040, United States

  • Arthrosi Investigative Site (672)

    Tarzana, California, 91356, United States

  • Arthrosi Investigative Site (673)

    Atlanta, Georgia, 30329, United States

  • Arthrosi Investigative Site (674)

    Louisville, Kentucky, 40205, United States

  • Arthrosi Investigative Site (675)

    Long Beach, California, 90806, United States

  • Arthrosi Investigative Site (676)

    Boise, Idaho, 83713, United States

  • Arthrosi Investigative Site (677)

    Austin, Texas, 78735, United States

  • Arthrosi Investigative Site (678)

    Indianapolis, Indiana, 46202, United States

  • Arthrosi Investigative Site (679)

    Overland Park, Kansas, 66209, United States

  • Arthrosi Investigative Site (680)

    Peoria, Arizona, 85381, United States

  • Arthrosi Investigative Site (681)

    Charlotte, North Carolina, 28277, United States

  • Arthrosi Investigative Site (683)

    Raleigh, North Carolina, 27607, United States

  • Arthrosi Investigative Site (684)

    Omaha, Nebraska, 68114, United States

  • Arthrosi Investigative Site (685)

    Bellevue, Washington, 98004, United States

  • Arthrosi Investigative Site (686)

    Las Vegas, Nevada, 89102, United States

  • Arthrosi Investigative Site (687)

    La Mesa, California, 91942, United States

  • Arthrosi Investigative Site (688)

    Plano, Texas, 75024, United States

  • Arthrosi Investigative Site (689)

    Prosper, Texas, 75078, United States

  • Arthrosi Investigative Site (693)

    Olive Branch, Mississippi, 38654, United States

  • Arthrosi Investigative Site (694)

    Palmetto Bay, Florida, 33157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.